These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8721533)

  • 21. Allergic contact dermatitis from estradiol and norethisterone acetate in a transdermal hormonal patch.
    Koch P
    Contact Dermatitis; 2001 Feb; 44(2):112-3. PubMed ID: 11205390
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in lipid levels due to transdermal administration of estradiol in the prevention of osteoporosis].
    Márk L; Kovács H; Búzás E
    Orv Hetil; 1996 Aug; 137(32):1785-6. PubMed ID: 8966021
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin reactions with transdermal estradiol therapy in a tropical environment.
    Bhathena RK; Anklesaria BS; Ganatra AM
    Int J Gynaecol Obstet; 1998 Feb; 60(2):177-9. PubMed ID: 9509960
    [No Abstract]   [Full Text] [Related]  

  • 25. Allergic contact dermatitis from transdermal buprenorphine.
    Vander Hulst K; Parera Amer E; Jacobs C; Dewulf V; Baeck M; Pujol Vallverdú RM; Giménez-Arnau A; Tennstedt D; Goossens A
    Contact Dermatitis; 2008 Dec; 59(6):366-9. PubMed ID: 19076888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hormone substitution therapy. Side-effects and compliance of various therapeutic regimens].
    Perrone G; Barillaro F; Bazzoffi R; Capri O; Critelli C; Galoppi P; Grande S; Santoro G
    Minerva Ginecol; 1999 Mar; 51(3):53-8. PubMed ID: 10352534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer risk in postmenopausal women using estrogen-only therapy.
    Lyytinen H; Pukkala E; Ylikorkala O
    Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergic contact dermatitis due to transdermal contraception patch.
    Stricker T; Sennhauser FH
    J Pediatr; 2006 Jun; 148(6):845. PubMed ID: 16769403
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrasorb.
    Chiechi LM
    IDrugs; 2004 Sep; 7(9):860-4. PubMed ID: 15470604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of transdermal estrogen replacement therapy on hyperandrogenicity and glucose homeostasis in postmenopausal women with NIDDM.
    Andersson B; Mattsson LA
    Acta Obstet Gynecol Scand; 1999 Mar; 78(3):260-1. PubMed ID: 10078591
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G; Ozmen B; Erguder I
    Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in C-reactive protein levels induced by different application forms of estrogen replacement therapy].
    Fait T; Vrablík M; Kostírová M; Trnková B
    Cas Lek Cesk; 2006; 145(7):571-4; discussion 574. PubMed ID: 16921788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone therapy: gallbladder risk is lower with a patch than a pill.
    Harv Womens Health Watch; 2008 Oct; 16(2):6-7. PubMed ID: 19054848
    [No Abstract]   [Full Text] [Related]  

  • 38. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 39. Postmenopausal hormone replacement therapy--advancement in drug delivery system.
    Bhattacharya SK
    J Indian Med Assoc; 1995 Oct; 93(10):370-1, 374. PubMed ID: 9053407
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral but not transdermal estrogen replacement therapy reduced level of tissue factor pathway inhibitor: cross-over designed study.
    Fait T; Vrablik M; Cibula D; Masata J; Hill M; Trnkova B
    Neuro Endocrinol Lett; 2006 Oct; 27(5):665-8. PubMed ID: 17159824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.